Efficacy and Safety of Rituximab in Autoimmune Disease-Associated Interstitial Lung Disease: A Prospective Cohort Study.

Natalia Mena VázquezRocío Redondo-RodríguezMarta Rojas-GimenezCarmen María Romero-BarcoSara Manrique ArijaRafaela Ortega-CastroAna Hidalgo CondeRocío Arnedo Díez de Los RíosEva Cabrera CésarFrancisco EspildoraMaría Carmen Aguilar-HurtadoIsabel Añón-OñateLorena Pérez-AlbaladejoManuel Abarca-CostalagoInmaculada Ureña GarnicaMaria Luisa Velloso-FeijooMaria Victoria Irigoyen-OyarzábalAntonio Fernandez-Nebro

Published in: Journal of clinical medicine (2022)

Lung function improved or stabilized in more than half of patients with CTD-ILD treated with RTX. Early treatment and combination with mycophenolate could reduce the risk of progression of ILD.

Keyphrases

interstitial lung disease
lung function
systemic sclerosis
rheumatoid arthritis
idiopathic pulmonary fibrosis
cystic fibrosis
chronic obstructive pulmonary disease
air pollution
diffuse large b cell lymphoma
drug induced
chronic lymphocytic leukemia